Identification and immunological characterization of a novel 40-kDa protein linked to CD98 antigen

Cell Structure and Function

Volumn 24, Issue 4, 1999, Pages 217-226

  Matsumoto, Yasuhiro ^a   Satoh Ueno, Kiyomi ^a   Yoshimura, Akari ^a   Hashimoto, Yoshiyuki ^b   Enomoto, Takemi ^a   Masuko, Takashi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b SASAKI INSTITUTE   (Japan)

Author keywords

Amino acid transporter; CD98; GP125 heavy chain (HC); GP125 light chain (LC); Malignant transformation; Monoclonal antibody (mAb)

Indexed keywords

ANTIBODY; ANTIGEN; GLYCOPROTEIN; MONOCLONAL ANTIBODY;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL FUSION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FROZEN SECTION; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPHOCYTE; MOLECULAR WEIGHT; MOUSE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; RAT; SPLEEN CELL; TONGUE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD98; ANTIGENS, SURFACE; BLOTTING, WESTERN; CARRIER PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; COLON; COLONIC NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HELA CELLS; HUMANS; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; RATS; RATS, INBRED F344; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0032757356     PISSN: 03867196     EISSN: None     Source Type: Journal    
DOI: 10.1247/csf.24.217     Document Type: Article

References (29)

1. BERTRAN, J., MAGAGNIN, S., WERNER, A., MARKOVICH, D., BIBER, J., TESTER, X., ZORZANO, A., KUHN, L.C., PALACIN, M., and MURER, H. 1992. Stimulation of system y(+)-like amino acid transport by the heavy chain of human 4F2 surface antigen in Xenopus laevis oocytes. Proc. Natl. Acad. Sci. USA, 89: 5606-5610.
2. BROER, S., BROER, A., and HAMPRECHT, B. 1995. The 4F2hc surface antigen is necessary for expression of system L-like neutral amino acid-transport activity in C5-BU-1 rat glioma cells: evidence from expression studies in Xenopus laevis oocytes. Biochem. J., 312: 863-870.
3. 2+ in human Jurkat T-cells. FEBS Lett., 395: 165-169.
4. FENCZIK, C.A., SETHI, T., RAMOS, J.W., HUGHES, P.E., and GINSBERG, M.H. 1997. Complementation of dominant suppression implicates CD98 in integrin activation. Nature, 390: 81-85.
5. HARA, K., KUDOH, H., ENOMOTO, T., HASHIMOTO, Y., and MASUKO, T. 1999. Malignant transformation of NIH3T3 cells by overexpression of early lymphocyte activation antigen CD98. Biochem. Biophys. Res. Commun., in press.
6. HASHIMOTO, Y., MASUKO, T., YAGITA, H., ENDO, N., KANAZAWA, J., and TAZAWA, J. 1983. A proliferation-associated rat cell surface antigen recognized by a murine monoclonal antibody. Jpn. J. Cancer Res., 74: 819-821.
7. HAYNES, B.F., HEHLER, M.E., MANN, D.L., EISENBARTH, G.S., SHELHAMER, J., MOSTOWSKI, H.S., THOMAS, C.A., STROMINGER, J.L., and FAUCI, A.S. 1981. Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J. Immunol., 126: 1409-1414.
8. KAMMA, H., ENDO, K., HORIGUCHI, H., IIJIMA, T., and OGATA, T. 1989. Lung cancer-associated monoclonal antibody 15 that recognizes cell growth-related membrane antigens gp85/45 and its growth-inhibitory effect on human lung cancer cells in vitro. Cancer Res., 49: 5118-5122.
9. KANAI, Y. and HEIDIGER, M.A. 1992. Primary structure and functional character-ization of a high-affinity glutamate transporter. Nature, 360: 467-471.
10. KANAI, Y., SEGAWA, H., MIYAMOTO, K., UCHINO, H., TAKEDA, E., and ENDOU, H. 1998. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J. Biol. Chem., 273: 23629-23632.
11. MACLEOD, C.L., FINLEY, K.D., and KAKUD, D.K. 1994. y(+)-type cationic amino acid transport: expression and regulation of the mCAT genes. J. Exp. Biol., 196: 109-121.
12. MANNION, B.A., KOLESNIKOVA, T.V., LIN, S.H., WANG, S., THOMPSON, N.C., and HEMLER, M.E. 1998. The light chain of CD98 is identified as E16/TA1 protein. J. Biol. Chem., 273: 33127-33129.
13. MASTROBERARDINO, L., SPINDLER, B., PFEIFFER, R., SKELLY, P.J., LOFFING, J., SHOEMAKER, C.B., and VERREY, F. 1998. Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family. Nature, 395: 288-291.
14. MASUKO, T., ABE, J., YAGITA, H., and HASHIMOTO, Y. 1985. Human bladder cancer cell-surface antigens recognized by murine monoclonal antibodies raised against T24 bladder cancer cells. Jpn. J. Cancer Res., 76: 386-394.
15. MASUKO, T., SUGAHARA, K., NAKAJIMA, S., and HASHIMOTO, Y. 1987. Altered expression of immunochemically detected cytochrome P-450 component(s) in nitrosamine-induced rat urinary lesion. Jpn. J. Cancer Res., 78: 840-845.
16. MATSUMOTO, Y., ENOMOTO, T., and MASUKO, T. 1999. Identification of truncated human glutamate transporter. Tohoku J. Exp. Med., 187: 173-182.
17. NAKAMURA, E., SATO, M., YANG, H., MIYAGAWA, F., HARASAKI, M., TOMITA, K., MATSUOKA, S., NOMA, A., IWAI, K., and MINATO, N. 1999. 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J. Biol. Chem., 274: 3009-3016.
18. OHGIMOTO, S., TABATA, N., SUGA, S., NISHIO, M., OHTA, H., TSURUDOME, M., KOMADA, H., KAWANO, M., WATANABE, N., and ITO, Y. 1995. Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp160-mediated cell fusion. FRP-1 and 4F2/CD98 are identical molecules. J. Immunol., 155: 3585-3592.
19. PATTERSON, J.A., EISINGER, M., HAYNES, B.F., BERGER, C.L., and EDELSON, R.L. 1984. Monoclonal antibody 4F2 reactive with basal layer keratinocytes: studies in the normal and a hyperproliferative state. J. Invest. Dermatol., 83: 210-213.
20. +-L-type by heterodimers of 4F2hc/CD98 and members of glyco-protein-associated amino acid transporter family. EMBO J., 18: 49-57.
21. TANAKA, T., MASUKO, T., and HASHIMOTO, Y. 1988. Appearance of a proliferation-associated antigen, gp125, on rat and human lymphocytes by co-stimulation with phorbol ester and calcium ionophore. J. Biochem., 103: 644-649.
22. WARREN, A.P., PATEL, K., MCCONKEY, D.J., and PALACIOS, R. 1996. CD98: a type II transmembrane glycoprotein expressed from the beginning of primitive and definitive hematopoiesis may play a critical role in the development of hematopoietic cells. Blood, 87: 3676-3687.
23. WELLS, R.G. and HEDIGER, M.A. 1992. Cloning of a rat kidney cDNA that stimulates dibasic and neutral amino acid transport and has sequence similarity to glucosidases. Proc. Natl. Acad. Sci. USA, 89: 5596-5600.
24. WELLS, R.G., LEE, W.S., KANAI, Y., LEIDEN, J.M., and HEDIGER, M.A. 1992. The 4F2 antigen heavy chain induces uptake of neutral and dibasic amino acids in Xenopus oocytes. J. Biol. Chem., 267: 15285-15288.
25. WOLF, D.A., WANG, S., PANZICA, M.A., BASSILY, N.H., and THOMPSON, N.L. 1996. Expression of a highly conserved oncofetal gene, TA1/E16, in human colon carcinoma and other primary cancers: Homology to Schistosoma mansoni amino acid permease and Caenorhabditis elegans gene products. Cancer Res., 56: 5012-5022.
26. YABE, N., MATSUYA, Y., YAMANE, I., and TAKADA, M. 1986. Enhanced formation of mouse hybridomas without hat treatment in a serum-free medium. In Vitro Cell Dev. Biol., 22: 363-368.
27. YAGITA, H., MASUKO, T., TAKAHASHI, N., and HASHIMOTO, Y. 1986. Monoclonal antibodies that inhibit activation and proliferation of lymphocytes. I. Expression of the antigen on monocytes and activated lymphocytes. J. Immunol., 136: 2055-2061.
28. YAGITA, H. and HASHIMOTO, Y. 1986. Monoclonal antibodies that inhibit activation and proliferation of lymphocytes. II. Requisite role of the monoclonal antibody-defined antigen systems in activation and proliferation of human and rat lymphocytes. J. Immunol., 136: 2062-2068.
29. YAGITA, H., MASUKO, T., and HASHIMOTO, Y. 1986. Inhibition of tumor cell growth in vitro by murine monoclonal anti-bodies that recognize a proliferation-associated cell surface antigen system in rats and humans. Cancer Res., 46: 1478-1484.